Cryoablation Combined With Tislelizumab Plus Lenvatinib in Patients With Melanoma Liver Metastasis
Clinical trial NCT05406466 · UNKNOWN
Trial details
- NCT number
- NCT05406466
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-15
- Primary completion
- 2024-07-10
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.